Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

BACKGROUND: The purpose of this study was to determine the efficacy of besifloxacin ophthalmic suspension 0.6% when used in the treatment of bacterial conjunctivitis infections due to Pseudomonas aeruginosa. METHODS: We undertook a post hoc analysis of clinical outcomes in patients with bacterial co...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverstein, Bruce E, Morris, Timothy W, Gearinger, Lynne S, DeCory, Heleen H, Comstock, Timothy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516496/
https://www.ncbi.nlm.nih.gov/pubmed/23233796
http://dx.doi.org/10.2147/OPTH.S35715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516496/
https://www.ncbi.nlm.nih.gov/pubmed/23233796
http://dx.doi.org/10.2147/OPTH.S35715

Ejemplares similares